Ann‐Marie Määttä

553 total citations
20 papers, 431 citations indexed

About

Ann‐Marie Määttä is a scholar working on Molecular Biology, Genetics and Biotechnology. According to data from OpenAlex, Ann‐Marie Määttä has authored 20 papers receiving a total of 431 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 11 papers in Genetics and 5 papers in Biotechnology. Recurrent topics in Ann‐Marie Määttä's work include Virus-based gene therapy research (11 papers), Cancer Research and Treatments (4 papers) and Herpesvirus Infections and Treatments (4 papers). Ann‐Marie Määttä is often cited by papers focused on Virus-based gene therapy research (11 papers), Cancer Research and Treatments (4 papers) and Herpesvirus Infections and Treatments (4 papers). Ann‐Marie Määttä collaborates with scholars based in Finland, France and United Kingdom. Ann‐Marie Määttä's co-authors include Seppo Ylä‐Herttuala, Jere T. Pikkarainen, Haritha Samaranayake, Jarmo Wahlfors, Riikka Pellinen, Ari Hinkkanen, Timo Liimatainen, Hanna P. Lesch, Kimmo Mäkinen and Arto Urtti and has published in prestigious journals such as PLoS ONE, Cancer Research and Journal of Controlled Release.

In The Last Decade

Ann‐Marie Määttä

20 papers receiving 397 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ann‐Marie Määttä Finland 14 255 216 85 54 45 20 431
Christopher Y. Chen United States 13 286 1.1× 264 1.2× 107 1.3× 55 1.0× 20 0.4× 20 464
Joung-Woo Choi South Korea 8 254 1.0× 235 1.1× 132 1.6× 69 1.3× 62 1.4× 8 392
Brian Cass Canada 11 502 2.0× 204 0.9× 94 1.1× 35 0.6× 47 1.0× 19 603
Romain Barbet France 10 384 1.5× 228 1.1× 66 0.8× 39 0.7× 9 0.2× 16 614
Patrick Voskamp Netherlands 9 255 1.0× 88 0.4× 41 0.5× 89 1.6× 26 0.6× 13 473
Sharon J. Carlson United States 11 208 0.8× 146 0.7× 86 1.0× 17 0.3× 19 0.4× 15 515
Daoyuan Xie China 8 176 0.7× 135 0.6× 150 1.8× 66 1.2× 61 1.4× 18 409
Thu-Thao T. Pham United States 4 763 3.0× 240 1.1× 66 0.8× 44 0.8× 20 0.4× 4 912
Jorge G. Gómez-Gutiérrez United States 17 354 1.4× 261 1.2× 229 2.7× 63 1.2× 82 1.8× 38 688
Stefan Ståhl Sweden 8 352 1.4× 93 0.4× 46 0.5× 16 0.3× 37 0.8× 9 500

Countries citing papers authored by Ann‐Marie Määttä

Since Specialization
Citations

This map shows the geographic impact of Ann‐Marie Määttä's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ann‐Marie Määttä with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ann‐Marie Määttä more than expected).

Fields of papers citing papers by Ann‐Marie Määttä

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ann‐Marie Määttä. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ann‐Marie Määttä. The network helps show where Ann‐Marie Määttä may publish in the future.

Co-authorship network of co-authors of Ann‐Marie Määttä

This figure shows the co-authorship network connecting the top 25 collaborators of Ann‐Marie Määttä. A scholar is included among the top collaborators of Ann‐Marie Määttä based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ann‐Marie Määttä. Ann‐Marie Määttä is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vapalahti, Katariina, et al.. (2020). High serum creatinine concentration is associated with metabolic perturbations in dogs. Journal of Veterinary Internal Medicine. 35(1). 405–414. 3 indexed citations
2.
Leinonen, Hanna, Igor Oruetxebarria, Haritha Samaranayake, et al.. (2019). Preclinical Proof-of-Concept, Analytical Development, and Commercial Scale Production of Lentiviral Vector in Adherent Cells. Molecular Therapy — Methods & Clinical Development. 15. 63–71. 19 indexed citations
3.
Leinonen, Hanna, Anna‐Kaisa Ruotsalainen, Ann‐Marie Määttä, et al.. (2012). Oxidative Stress-Regulated Lentiviral TK/GCV Gene Therapy for Lung Cancer Treatment. Cancer Research. 72(23). 6227–6235. 37 indexed citations
4.
Samaranayake, Haritha, et al.. (2012). Specific Inhibition of SRC Kinase Impairs Malignant Glioma Growth In Vitro and In Vivo. Molecular Therapy — Nucleic Acids. 1. e19–e19. 6 indexed citations
5.
Kaikkonen, Minna U., Marjo Jauhiainen, David L. Selwood, et al.. (2012). Targeted delivery via avidin fusion protein: Intracellular fate of biotinylated doxorubicin derivative and cellular uptake kinetics and biodistribution of biotinylated liposomes. European Journal of Pharmaceutical Sciences. 47(5). 848–856. 17 indexed citations
6.
Raki, Mari, Kim Bergström, Päivi Uutela, et al.. (2012). Pre-Targeting and Direct Immunotargeting of Liposomal Drug Carriers to Ovarian Carcinoma. PLoS ONE. 7(7). e41410–e41410. 43 indexed citations
7.
Kontturi, Leena-Stiina, Marjo Yliperttula, Pyry I. Toivanen, et al.. (2011). A laboratory-scale device for the straightforward production of uniform, small sized cell microcapsules with long-term cell viability. Journal of Controlled Release. 152(3). 376–381. 30 indexed citations
8.
Lesch, Hanna P., et al.. (2011). Requirements for baculoviruses for clinical gene therapy applications. Journal of Invertebrate Pathology. 107. S106–S112. 16 indexed citations
9.
Turhanen, Petri, et al.. (2011). A novel strategy for the synthesis of enzymatically stable biotin–DOTA conjugates for in vivo use. MedChemComm. 2(9). 886–886. 2 indexed citations
10.
Samaranayake, Haritha, Ann‐Marie Määttä, Jere T. Pikkarainen, & Seppo Ylä‐Herttuala. (2010). Future Prospects and Challenges of Antiangiogenic Cancer Gene Therapy. Human Gene Therapy. 21(4). 381–396. 19 indexed citations
11.
Wirth, Thomas, Haritha Samaranayake, Jere T. Pikkarainen, Ann‐Marie Määttä, & Seppo Ylä‐Herttuala. (2009). Clinical trials for glioblastoma multiforme using adenoviral vectors.. PubMed. 11(5). 485–92. 19 indexed citations
12.
Lesch, Hanna P., Jere T. Pikkarainen, Minna U. Kaikkonen, et al.. (2009). Avidin Fusion Protein-Expressing Lentiviral Vector for Targeted Drug Delivery. Human Gene Therapy. 20(8). 871–882. 12 indexed citations
13.
Määttä, Ann‐Marie, Haritha Samaranayake, Jere T. Pikkarainen, Thomas Wirth, & Seppo Ylä‐Herttuala. (2009). Adenovirus Mediated Herpes Simplex Virus-Thymidine Kinase/Ganciclovir Gene Therapy for Resectable Malignant Glioma. Current Gene Therapy. 9(5). 356–367. 38 indexed citations
14.
Määttä, Ann‐Marie, Kimmo Mäkinen, Timo Liimatainen, et al.. (2008). Replication competent Semliki Forest virus prolongs survival in experimental lung cancer. International Journal of Cancer. 123(7). 1704–1711. 36 indexed citations
15.
Hinkkanen, Ari, Ann‐Marie Määttä, Timo Liimatainen, et al.. (2008). Oncolytic Semliki Forest Virus Vector as a Novel Candidate against Unresectable Osteosarcoma. Cancer Research. 68(20). 8342–8350. 40 indexed citations
16.
Määttä, Ann‐Marie, Timo Liimatainen, Tiina Wahlfors, et al.. (2007). Evaluation of cancer virotherapy with attenuated replicative Semliki forest virus in different rodent tumor models. International Journal of Cancer. 121(4). 863–870. 27 indexed citations
17.
Määttä, Ann‐Marie, Heli Venhoranta, Tanja Hakkarainen, et al.. (2006). Transcriptional targeting of virus-mediated gene transfer by the human hexokinase II promoter. International Journal of Molecular Medicine. 18(5). 901–8. 5 indexed citations
18.
Määttä, Ann‐Marie, Tiina Wahlfors, Markus Vähä‐Koskela, et al.. (2006). 41. Evaluation of Lung Cancer Virotherapy with Oncolytic Semliki Forest Virus Using Immunodeficient Rodent Tumor Model. Molecular Therapy. 13. S17–S17. 1 indexed citations
19.
Määttä, Ann‐Marie, et al.. (2004). Osteosarcoma and chondrosarcoma as targets for virus vectors and herpes simplex virus thymidine kinase/ganciclovir gene therapy. International Journal of Molecular Medicine. 13(5). 705–10. 28 indexed citations
20.
Määttä, Ann‐Marie, et al.. (2004). Non-small cell lung cancer as a target disease for herpes simplex type 1 thymidine kinase - ganciclovir gene therapy. International Journal of Oncology. 24(4). 943–9. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christopher Y. Chen Breakdown of academic impact, for papers by Joung-Woo Choi Breakdown of academic impact, for papers by Brian Cass Breakdown of academic impact, for papers by Romain Barbet Breakdown of academic impact, for papers by Patrick Voskamp Breakdown of academic impact, for papers by Sharon J. Carlson Breakdown of academic impact, for papers by Daoyuan Xie Breakdown of academic impact, for papers by Thu-Thao T. Pham Breakdown of academic impact, for papers by Jorge G. Gómez-Gutiérrez Breakdown of academic impact, for papers by Stefan Ståhl
Rankless by CCL
2026